Approval for pesticide toxicity testing in humans draws criticism

Article Abstract:

The US Environmental Protection Agency (EPA) issues a ruling that permits toxicity testing of pesticides on humans ending a 2005 moratorium on such testing imposed by the US Congress and signed by President Bush. The EPA is confident that the stringent ethical standards it has established will ensure that the ruling is not abused but its critics maintain that the many loopholes will enable pesticide manufacturers to sidestep regulations leaving human lives at risk.

Legal issues & crime, Government regulation (cont), Government regulation, Management dynamics, Pesticide and Other Agricultural Chemical Manufacturing, Pesticides & Other Ag Chemicals, Legal/Government Regulation, Agricultural chemicals, not elsewhere classified, Pesticide Preparations, Predator Control Products, Predator Poisons, Management, Laws, regulations and rules, Testing, United States. Environmental Protection Agency, Human experimentation in medicine, Human medical experimentation, Company business management, Pesticides

---

Researchers critical of TV drug ads

Article Abstract:

A study reports that television advertisements of prescription drugs offer limited educational value like information about disease causes and those at risk, but use emotional appeals to suggest that the medication would help consumers regain control over their life. The researchers believe that the U.S. Food and Drug Administration (FDA) must oversee such advertising and impose conditions or limits where needed to protect public health.

Drugs & Pharmaceuticals, Pharmaceutical and Medicine Manufacturing, Pharmaceutical Preparation Manufacturing, Radio, TV, publisher representatives, TV Advertising, Media Representatives, Advertising, Pharmaceutical preparations, Advertising Activity, Metabolic Agents NEC, Metabolic Agents, Drugs, Television advertising

---

Trials planned for testing nonsurgical approach to replacing heart valves

Article Abstract:

Researchers are testing an artificial heart valve that can be inserted into a catheter and pushed up a patient's leg vein to the heart, pushing aside the damaged valve and inserting the new one. This would allow elderly patients to avoid open-heart surgery. If the treatment is successful, it could eventually replace open-heart surgery altogether for replacing heart valves.

Biological Product (except Diagnostic) Manufacturing, Biosynthetic Heart Valves, Innovations, Product information, Medical equipment and supplies industry, Medical equipment industry, Heart valve replacement, Heart valve prosthesis, Artificial heart valves, Percutaneous Valve Technologies

Similar abstracts:

• Abstracts: A question of faith. NT reveals major jobs crisis. A good career move
• Abstracts: Cardiac morbidity and related mortality in children with HIV infection. Incidence, causes and outcomes of dilated cardiomyopathy in children
• Abstracts: Interleukin-1 expression by neutrophils in rheumatoid arthritis. Receptor expression in synovial fluid neutrophils from patients with rheumatoid arthritis
• Abstracts: Hospitals binge on practice buy-outs. Savings may be FTC test in hospital, doctor mergers. Justice Dept. squelches Baton Rouge PHO
• Abstracts: Behavioral surveillance: current perspectives, and its role in catalyzing action. Distribution of the CCR5 gene 32-base pair deletion and CCR5 expression in Chinese minorities

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.